Concepedia

Publication | Open Access

Effect of sorafenib combined with cytostatic agents on hepatoblastoma cell lines and xenografts

31

Citations

22

References

2012

Year

Abstract

The combination of sorafenib with cisplatin might be a promising treatment option for high risk or recurrent HB.

References

YearCitations

Page 1